Lessons Learned From Human Papillomavirus Vaccination to Increase Uptake of Adolescent COVID-19 Vaccination

UMMS Affiliation

Division of Preventive and Behavioral Medicine, Department of Population and Quantitative Health Sciences; Department of Pediatrics; Graduate School of Biomedical Sciences; UMass Worcester Prevention Research Center

Publication Date


Document Type



Behavioral Medicine | Community Health and Preventive Medicine | Health Services Administration | Health Services Research | Infectious Disease | Pediatrics | Preventive Medicine | Public Health Education and Promotion


Uptake of COVID-19 vaccination among adolescents has been low and highly variable across the United States. As of July 2021, the most recently available national data, 42% of adolescents ages 12–17 had received at least one dose of the COVID-19 vaccine, but that percentage varied widely from state to state. Low vaccination rates threaten to prolong the pandemic and pose a health risk to unvaccinated adolescents as well as their families and social networks. To promote COVID-19 vaccinations for adolescents, it will be valuable to explore lessons learned about human papillomavirus (HPV) vaccination in this population. In this commentary, we outline the similarities between the HPV and COVID-19 vaccines and offer three recommendations that can be applied to efforts for adolescent COVID-19 vaccination promotion and delivery.

DOI of Published Version



Ryan G, Askelson NM, Miotto MB, Goulding M, Rosal MC, Pbert L, Lemon SC. Lessons Learned From Human Papillomavirus Vaccination to Increase Uptake of Adolescent COVID-19 Vaccination. J Adolesc Health. 2022 Mar;70(3):359-360. doi: 10.1016/j.jadohealth.2021.11.025. Epub 2021 Dec 16. PMID: 35183319; PMCID: PMC8674509. Link to article on publisher's site

Journal/Book/Conference Title

The Journal of adolescent health : official publication of the Society for Adolescent Medicine

Related Resources

Link to Article in PubMed

PubMed ID